Literature DB >> 26253133

Nonamyloid tumoral light-chain-deposition disease (aggregoma) of the paraspinal region.

Ayushi Singh1, Linda Okonkwo2, Jason C Hoffmann1, Joseph P Mazzie1, Amanjit S Baadh3.   

Abstract

Aggregomas are rare localized masses of monoclonal nonamyloid immunoglobulin light-chain deposits. To date, there have been only a few reports of isolated aggregomas, with the majority detailing renal, lymph node and brain deposition. We present a rare case of paraspinal aggregoma in a 67-year-old female who presented with a complaint of cough and chest pain. Imaging demonstrated a left-sided paravertebral mass extending from T7-T10. Pathological analysis showed lamellar deposition of extracellular eosinophilic material with an associated lymphoplasmacytic nonamyloid infiltrate. To our knowledge, this is the first report of a paraspinal aggregoma. While exceedingly rare, this tumor can be included in the radiologic differential diagnosis of paravertebral soft tissue tumors in adults. The observation of our case adds to the limited understanding of the etiology, pathogenesis, natural history, and treatment of nonamyloid light-chain depositions.

Entities:  

Keywords:  Aggregoma; Amyloidoma; LCDD; Lymphoma; Paraspinal; Paraspinal mass

Mesh:

Substances:

Year:  2015        PMID: 26253133     DOI: 10.1007/s00256-015-2223-4

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  15 in total

1.  Primary amyloidoma of the cervical spine.

Authors:  S S Hwang; Y H Park; J Y Kim; S L Jung; M I Ahn; C K Park; E D Chang
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

Review 2.  Peripheral and cranial nerve sheath tumors.

Authors:  Maciej M Mrugala; Tracy T Batchelor; Scott R Plotkin
Journal:  Curr Opin Neurol       Date:  2005-10       Impact factor: 5.710

Review 3.  Imaging of focal amyloid depositions in the head, neck, and spine: amyloidoma.

Authors:  Hemant Parmar; T Rath; M Castillo; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

Review 4.  Light chain deposition disease: novel biological insights and treatment advances.

Authors:  V H Jimenez-Zepeda
Journal:  Int J Lab Hematol       Date:  2012-04-04       Impact factor: 2.877

5.  Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits ('aggregoma'): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses.

Authors:  Agueda Rostagno; Glauco Frizzera; Lourdes Ylagan; Asok Kumar; Jorge Ghiso; Gloria Gallo
Journal:  Br J Haematol       Date:  2002-10       Impact factor: 6.998

6.  Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.

Authors:  Pierre Ronco; Emmanuelle Plaisier; Béatrice Mougenot; Pierre Aucouturier
Journal:  Clin J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 8.237

Review 7.  Primary bone lymphoma: radiographic-MR imaging correlation.

Authors:  Anant Krishnan; Ali Shirkhoda; Jamshid Tehranzadeh; Ali R Armin; Ronald Irwin; Kimberly Les
Journal:  Radiographics       Date:  2003 Nov-Dec       Impact factor: 5.333

8.  Amyloid-like pulmonary nodules, including localized light-chain deposition: clinicopathologic analysis of three cases.

Authors:  Andras Khoor; Jeffrey L Myers; Henry D Tazelaar; Paul J Kurtin
Journal:  Am J Clin Pathol       Date:  2004-02       Impact factor: 2.493

9.  A case of isolated light chain deposition disease in the duodenum.

Authors:  Hee-Jun Kim; Eunkyung Park; Tae Jin Lee; Jae Hyuk Do; Young Joo Cha; Sang Jae Lee
Journal:  J Korean Med Sci       Date:  2012-01-27       Impact factor: 2.153

10.  Primary cerebral low-grade B-cell lymphoma, monoclonal immunoglobulin deposition disease, cerebral light chain deposition disease and "aggregoma": an update on classification and diagnosis.

Authors:  Marco Skardelly; Georgios Pantazis; Sotirios Bisdas; Guenther C Feigl; Martin U Schuhmann; Marcos S Tatagiba; Rainer Ritz
Journal:  BMC Neurol       Date:  2013-08-15       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.